Trigonellamide

DB11710InvestigationalSmall molecule

Trigonellamide is under investigation in clinical trial NCT01930240 (The Safety of a Hypolipidemic Agent in Healthy Normal Volunteers).

Chemical structure of Trigonellamide
Formula / weight
C7H9N2O · 137.1592 g/mol (avg)
Also known as
1-MNA
Code names
Tria 662

Resolves to

Compound
UNIIUM47085BXCCAS3106-60-3ChEMBLCHEMBL71733ChEBI16797PubChem457KEGGC02918
Structure
InChIKeyLDHMAVIPBRSVRG-UHFFFAOYSA-OSMILESC[N+]1=CC=CC(=C1)C(N)=O
Targets
P40261NNMT

What you can answer from here — as of August 29, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Trigonellamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In